Boettger Susanne, Bergman Meredith, Jenewein Josef, Boettger Soenke
Department of Pediatrics,University Children's Hospital, University of Zurich,Zurich,Switzerland.
Department of Psychiatry,Langone Medical Center,Bellevue Hospital Center,New York University,New York,New York.
Palliat Support Care. 2015 Oct;13(5):1275-81. doi: 10.1017/S1478951514001266. Epub 2014 Oct 30.
Studies on decisional capacity have primarily focused on cognitive disorders, whereas noncognitive disorders remain understudied. The purpose of our study was to assess decisional capacity across a wide spectrum of medical and psychiatric disorders.
More than 2,500 consecutive consults were screened for decisional capacity, and 336 consults were reviewed at Bellevue Hospital Center in New York. Sociodemographic and medical variables, medical and psychiatric diagnoses, as well as decisional capacity assessments were recorded and analyzed.
Consults for decisional capacity were most commonly called for in male patients with cognitive and substance abuse disorders. Less commonly, consults were called for patients with mood or psychotic disorders. Overall, about two thirds of patients (64.7%) were deemed not to have decisional capacity. Among medical diagnoses, neurological disorders contributed to decisional incapacity, and among the psychiatric diagnoses, cognitive disorders were most frequently documented in cases lacking decisional capacity (54.1%) and interfered more commonly with decisional capacity than substance abuse or psychotic disorders (37.2 and 25%). In contrast, patients with mood disorders usually retained their decisional capacity (32%). Generally, the primary treatment team's assessment was accurate and was confirmed by the psychiatric service.
Although decisional capacity assessments were most commonly requested for patients with substance abuse and cognitive disorders, the latter generally affected the ability to make healthcare decisions the most. Further, cognitive disorders were much more likely to impair the ability to make appropriate healthcare decisions than substance abuse or psychotic disorders.
关于决策能力的研究主要集中在认知障碍方面,而非认知障碍仍未得到充分研究。我们研究的目的是评估广泛的医学和精神疾病患者的决策能力。
对超过2500例连续的会诊进行决策能力筛查,在纽约贝尔维尤医院中心对336例会诊进行了回顾。记录并分析了社会人口统计学和医学变量、医学和精神疾病诊断以及决策能力评估。
决策能力会诊最常见于患有认知障碍和药物滥用障碍的男性患者。较少见的是,为患有情绪或精神障碍的患者进行会诊。总体而言,约三分之二的患者(64.7%)被认为没有决策能力。在医学诊断中,神经系统疾病导致决策能力丧失,在精神疾病诊断中,认知障碍在缺乏决策能力的病例中记录最为频繁(54.1%),并且比药物滥用或精神障碍(37.2%和25%)更常干扰决策能力。相比之下,患有情绪障碍的患者通常保留其决策能力(32%)。一般来说,初级治疗团队的评估是准确的,并得到了精神科服务的证实。
尽管决策能力评估最常针对药物滥用和认知障碍患者进行,但后者通常对做出医疗决策的能力影响最大。此外,与药物滥用或精神障碍相比,认知障碍更有可能损害做出适当医疗决策的能力。